Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility (Composite) Nbr of analysts
25
19
Average 22
Weighted average by Cap. 21
Diagnostic & Testing Substances Manufacturers